Biomotum key facts
as of Oct 2026- Developer of robotic exoskeletons designed to address the rapidly increasing number of people with poor health due to difficulty walking.
- Biomotum is valued at approximately $9.5M as of Oct 2026, set at its seed round, Jul 2023; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $3.5M across 1 recorded rounds; the latest was Seed Round ($660K) in Oct 2020.
- Notable investors include Creative Destruction Lab, MassChallenge, National Institutes of Health, Portland Seed Fund, Elevate Capital — 17 tracked in total.
- Biomotum has filed 3 Form Ds with the SEC since 2020, most recently Mar 2022 ($200K sold to 2 investors).
- Status: Privately Held (backing).
Valued at $9.5M at its seed round, Jul 2023. Nothing has traded since.
- ·The complete investor list: 17 names
- ·Watch Biomotum: the Monday email on marks, rounds and moves
Biomotum funding rounds
1 roundsWho backs Biomotum
17+Biomotum valuation
Biomotum was valued at $9.5 million at its seed round in Jul 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Biomotum raised?
Biomotum has raised $3.5 million in total; 1 of its rounds is on record. The largest on record was a $660,000 seed round in Oct 2020.
Biomotum has filed 3 Form Ds with the SEC since 2020, most recently in Mar 2022 ($200,000 sold to 2 investors).
Biomotum investors
17 investors are on record for Biomotum, including Creative Destruction Lab, MassChallenge, National Institutes of Health and Portland Seed Fund. The seed round in Oct 2020 drew 3 investors.
About Biomotum
Developer of robotic exoskeletons designed to address the rapidly increasing number of people with poor health due to difficulty walking. The company's connected, wearable systems combine the benefits of advanced assistive technology and deliver an easy-to-use therapeutic system that includes real-time training insights, tele-rehab compatibility, and embedded progress reporting, enabling individuals affected by neurologic disorders, including stroke and cerebral palsy.
- Sector
- Healthcare
- HQ
- Portland, OR, United States
- Founded
- 2019
- Employees
- 4
- Website
- biomotum.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.